The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery

Study Overview
=================
Brief Summary
-----------------
In this study, between 15 November 2022 - 15 November 2023, who met the inclusion and exclusion criteria, a total of 82 patients who are on the 2nd or 3rd day after the surgery and who are hospitalized in the cardiovascular surgery intensive care clinic will be recruited.

Detailed Description
-----------------
The patient will be put on virtual reality glasses five minutes before the chest tube is removed. Afterwards, it will continue to be watched while the tube is taken and virtual reality glasses will be watched for another five minutes. Pain level and hemodynamic variables will be checked before, during, and 15 and 30 minutes after virtual reality glasses are watched. The participants in the control group will receive routine treatment and care, and their data will be collected at the same time as those in the study group. Hemodynamic variables will be monitored and recorded on the monitor. Virtual reality glasses application is a method without any side effects. During the research, any adverse condition (vision problem, nausea, dizziness, etc.) related to the use of virtual glasses will be observed by the researcher. Since virtual reality glasses will be used in another patient after being used on one patient, disinfection will be made in line with the company's recommendations, taking into account the pandemic conditions. Throughout the application, feedback will be received from the patients by the researchers.

Official Title
-----------------
The Effect of Virtual Reality Glasses Applied on Chest Tube Removal After Open Heart Surgery on Pain Level and Hemodynamic Variables

Conditions
-----------------
Pain, Hemodynamic Instability

Intervention / Treatment
-----------------
* Other: virtual reality


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Agreeing to participate in the research (signing the Informed Consent Form), Conscious and cooperative, Stable hemodynamic status, Speaks and understands Turkish, Over 18 years old, On the 2nd and 3rd day after open heart surgery, Having chest tube, No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied, No active COVID-19 infection, Patients without any psychiatric diagnosis Exclusion Criteria: Agreeing to participate in the research (signing the Informed Consent Form), Not conscious, Not cooperative Unstable hemodynamic status, Speaks and understands Turkish, who are under the age of 18, On the 0th or 1st day after surgery, No chest tube, Has sensitivity or trauma in the area (for the study group) where the virtual reality Active COVID-19 infection, Patients with a psychiatric diagnosis

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: The study was planned as a prospective, two-armed (1:1), randomized controlled experimental study. This randomized controlled trial will be reported according to the CONSORT guidelines.
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Virtual Reality application group<br>Virtual reality glasses (VR Box Virtual Reality Headset 3D Vr Glasses V2.0 2020 model) compatible with the mobile phone (Lenovo P2a42) with the Android operating system will be worn and the patient will be watched (underwater world, open-air museum tours, beach trips and nature scenes) by patients for an average of 10 minutes during chest tube removal. | Other: virtual reality<br>* Virtual reality glasses application is a method without any side effects. Patients will be treated for an average of 10 minutes. Data will be collected before, during, immediately after the application, at the 15th and 30th minutes.<br>|
| No Intervention: Standard of care<br>Only standard care will be given and no application will be made. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pain evaluated using the Visual Analogue Scale | Visual Analogue Scala has been developed to convert some values that cannot be measured numerically into numeric values. The VAS, which is a safe and easily applicable scale tool generally accepted in the world literature, consists of a 10 cm long line and there are subjective descriptive expressions at both ends of the scale (0 cm = none at all and 10 cm = highest degree.) | Change from before implementation up to 30 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Systolic blood pressure | Systolic blood pressure (SBP), mmHg | Change from before implementation up to 30 minutes | 
| Diastolic blood pressure | Diastolic blood pressure (DBP), mmHg | Change from before implementation up to 30 minutes | 
| Heart rate | Beats per minute | Change from before implementation up to 30 minutes | 
| Respiratory rate | Lung breathing | Change from before implementation up to 30 minutes | 
| Peripheral oxygen saturation | %, percentage of oxygenated hemoglobin in peripheral arterial blood | Change from before implementation up to 30 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
pain, Virtual reality glasses, open heart surgery, hemodynamic